Biparietal tDCS appears to be a promising intervention for improving insight in schizophrenia. Future research should explore its adjunctive use with medication to enhance treatment adherence.
Song et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: